NV

Nandakumar Vitthalrao Khedekar

Active Director Director DIN 10528118
DIN 10528118 First appointment Feb 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nandakumar Vitthalrao Khedekar

Data last updated:

Nandakumar Vitthalrao Khedekar is a Director at Ehretia Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10528118
Primary Designation Director
Industry Paper
First Appointment 28 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ehretia Pharma Private Limited U21001MH2024PTC420304
Director28 Feb 20242024Active

Board colleagues of Nandakumar Vitthalrao Khedekar

NameDINCompanyDesignation
Kiran Tanaji Jadhav10528119Ehretia Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ehretia Pharma Private Limited
Premium access

Shareholding and investment profile for Nandakumar Vitthalrao Khedekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandakumar Vitthalrao Khedekar

Nandakumar Vitthalrao Khedekar currently holds 1 directorship: Ehretia Pharma Private Limited (Director, since 28 Feb 2024).

Nandakumar Vitthalrao Khedekar was first appointed on 28 Feb 2024 as Director at Ehretia Pharma Private Limited.

The current boards of Nandakumar Vitthalrao Khedekar's companies include Kiran Tanaji Jadhav (Ehretia Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available